KUALA LUMPUR (Aug 3): LYC Healthcare Bhd (KL:LYC) faces a trading suspension from Aug 10 if it fails to submit its overdue annual report for the financial year ended March 31, 2026 (FY2026), by this Friday (Aug 7).
The operator of confinement centres and aesthetic clinics missed the July 31 deadline to submit its annual report, including its audited financial statements and the auditors’ and directors’ reports, as required under Bursa Malaysia’s listing requirements.
“..In the event that LYC is unable to submit the outstanding annual report 2026 on or before 7 August 2026, the trading in the above company’s securities will be suspended with effect from 9.00am, Monday, 10 August 2026 until further notice,” according to LYC’s filing with Bursa Malaysia.
Under Bursa Malaysia’s listing rules, companies that fail to issue their outstanding financial statements within five market days after the submission deadline will have their securities suspended on the following market day. Companies that remain in default for six months may face delisting proceedings, in addition to any enforcement action by Bursa Malaysia.
On July 28, LYC said it was likely to miss the July 31 deadline following the appointment of SBY Partners PLT as its new external auditor on March 6, after Crowe Malaysia PLT resigned on Feb 26 over a disagreement on audit fees. The group said it needed more time to complete the audit with SBY Partners, but expected to issue its FY2026 annual report and audited financial statements by Aug 7.
LYC has been loss-making since FY2012. For FY2026, its net loss widened to RM23.27 million from RM17.07 million a year earlier, while revenue fell 13.7% to RM134.19 million from RM155.52 million.
As at end-March, the group had accumulated losses of RM112.9 million, cash and bank balances of RM17.47 million, and total borrowings of RM73.3 million, the bulk of which comprised redeemable preference shares.
Shares of LYC were unchanged at one sen on Monday, giving it a market capitalisation of RM7.4 million.